323 related articles for article (PubMed ID: 18676439)
1. Perivascular spaces--MRI marker of inflammatory activity in the brain?
Wuerfel J; Haertle M; Waiczies H; Tysiak E; Bechmann I; Wernecke KD; Zipp F; Paul F
Brain; 2008 Sep; 131(Pt 9):2332-40. PubMed ID: 18676439
[TBL] [Abstract][Full Text] [Related]
2. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
[TBL] [Abstract][Full Text] [Related]
3. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z
Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
[TBL] [Abstract][Full Text] [Related]
4. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
5. Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
Antulov R; Weinstock-Guttman B; Cox JL; Hussein S; Durfee J; Caiola C; Dwyer MG; Bergsland N; Abdelrahman N; Stosic M; Hojnacki D; Munschauer FE; Miletic D; Zivadinov R
Mult Scler; 2009 Mar; 15(3):345-54. PubMed ID: 19028830
[TBL] [Abstract][Full Text] [Related]
6. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
Patankar TF; Baldwin R; Mitra D; Jeffries S; Sutcliffe C; Burns A; Jackson A
J Affect Disord; 2007 Jan; 97(1-3):265-70. PubMed ID: 16919335
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
8. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
Zhao Y; Traboulsee A; Petkau AJ; Li D
Neurology; 2008 Mar; 70(13 Pt 2):1092-7. PubMed ID: 18003938
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Khalil M; Enzinger C; Langkammer C; Tscherner M; Wallner-Blazek M; Jehna M; Ropele S; Fuchs S; Fazekas F
Mult Scler; 2009 Sep; 15(9):1048-54. PubMed ID: 19556316
[TBL] [Abstract][Full Text] [Related]
10. Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration?
Kilsdonk ID; Steenwijk MD; Pouwels PJ; Zwanenburg JJ; Visser F; Luijten PR; Geurts J; Barkhof F; Wattjes MP
Mult Scler; 2015 Feb; 21(2):155-62. PubMed ID: 25013150
[TBL] [Abstract][Full Text] [Related]
11. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag BM; Knol DL; Polman CH; Barkhof F; Vrenken H;
Mult Scler; 2009 Apr; 15(4):465-71. PubMed ID: 19091881
[TBL] [Abstract][Full Text] [Related]
12. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
13. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
14. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
15. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
[TBL] [Abstract][Full Text] [Related]
17. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
Laplaud DA; Berthelot L; Miqueu P; Bourcier K; Moynard J; Oudinet Y; Guillet M; Ruiz C; Oden N; Brouard S; Guttmann CR; Weiner HL; Khoury SJ; Soulillou JP
J Neuroimmunol; 2006 Aug; 177(1-2):151-60. PubMed ID: 16806500
[TBL] [Abstract][Full Text] [Related]
18. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
Vaneckova M; Seidl Z; Krasensky J; Havrdova E; Horakova D; Dolezal O; Burgetova A; Masek M
Eur Neurol; 2009; 61(5):278-84. PubMed ID: 19295214
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
[TBL] [Abstract][Full Text] [Related]
20. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
